Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for I nternational B lood and M arrow T ransplant R esearch cohort analysis-Reference-Cited by-同舟云学术

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for I nternational B lood and M arrow T ransplant R esearch cohort analysis

Published:2017-01-24 Issue:11 Volume:123 Page:2035-2042
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Michelis Fotios V.¹,Gupta Vikas¹,Zhang Mei‐Jie²³,Wang Hai‐Lin²,Aljurf Mahmoud⁴,Bacher Ulrike⁵⁶,Beitinjaneh Amer⁷,Chen Yi‐Bin⁸,DeFilipp Zachariah⁹,Gale Robert Peter¹⁰,Kebriaei Partow¹¹,Kharfan‐Dabaja Mohamed¹²,Lazarus Hillard M.¹³,Nishihori Taiga¹²,Olsson Richard F.¹⁴¹⁵,Oran Betul¹¹,Rashidi Armin¹⁶,Rizzieri David A.¹⁷,Tallman Martin S.¹⁸,de Lima Marcos¹³,Khoury H. Jean⁹,Sandmaier Brenda M.¹⁹²⁰,Weisdorf Daniel²¹,Saber Wael²,

Affiliation:

1. Allogeneic Blood and Marrow Transplant Program, Princes Margaret Cancer CentreToronto Ontario Canada

2. Center for International Blood and Marrow Transplant Research, Department of MedicineMedical College of WisconsinMilwaukee Wisconsin

3. Division of Biostatistics, Institute for Health and Society, Medical College of WisconsinMilwaukee Wisconsin

4. Department of OncologyKing Faisal Specialist Hospital Center & ResearchRiyadh Saudi Arabia

5. Department of Hematology/OncologyUniversity Medicine GottingenGottingen Germany

6. Interdisciplinary Clinic for Stem Cell TransplantationUniversity Cancer Center HamburgHamburg Germany

7. University of MiamiMiami Florida

8. Division of Hematology/Oncology, Massachusetts General HospitalBoston Massachusetts

9. Emory University HospitalAtlanta Georgia

10. Hematology Research Centre, Division of Experimental Medicine, Department of MedicineImperial College LondonLondon United Kingdom

11. Department of Stem Cell Transplantation, Division of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHouston Texas

12. Department of Blood and Marrow TransplantationH. Lee Moffitt Cancer Center and Research InstituteTampa Florida

13. Department of Medicine, Seidman Cancer CenterUniversity Hospitals Case Medical CenterCleveland Ohio

14. Division of Therapeutic Immunology, Department of Laboratory MedicineKarolinska InstitutetStockholm Sweden

15. Centre for Clinical Research SormlandUppsala UniversityUppsala Sweden

16. Division of OncologyWashington University School of MedicineSt. Louis Missouri

17. Division of Hematologic Malignancies and Cellular TherapyDuke UniversityDurham North Carolina

18. Leukemia Service, Department of MedicineMemorial Sloan Kettering Cancer CenterNew York New York

19. Division of Medical OncologyUniversity of WashingtonSeattle Washington

20. Clinical Research Division, Fred Hutchinson Cancer Research CenterSeattle Washington

21. Division of Hematology, Oncology, and Transplantation, Department of MedicineUniversity of Minnesota Medical CenterMinneapolis Minnesota

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

Office of Naval Research

Health Resources and Services Administration

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30567

Reference30 articles.

1. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005

2. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

3. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

4. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

5. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2023-05-03

2. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients;Leukemia;2022-10-30

3. Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation;Leukemia & Lymphoma;2021-12-09

4. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved;Blood Reviews;2021-05

5. Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation;Biology of Blood and Marrow Transplantation;2020-01